ITTO20100237A1 - Immunoglobuline intere della classe delle igg per l'uso come medicamento antinfluenzale - Google Patents

Immunoglobuline intere della classe delle igg per l'uso come medicamento antinfluenzale

Info

Publication number
ITTO20100237A1
ITTO20100237A1 IT000237A ITTO20100237A ITTO20100237A1 IT TO20100237 A1 ITTO20100237 A1 IT TO20100237A1 IT 000237 A IT000237 A IT 000237A IT TO20100237 A ITTO20100237 A IT TO20100237A IT TO20100237 A1 ITTO20100237 A1 IT TO20100237A1
Authority
IT
Italy
Prior art keywords
antinfluenous
immunoglobulines
medication
whole
igg class
Prior art date
Application number
IT000237A
Other languages
English (en)
Inventor
Roberto Burioni
Massimo Clementi
Original Assignee
Pomona Biotechnologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pomona Biotechnologies Llc filed Critical Pomona Biotechnologies Llc
Priority to IT000237A priority Critical patent/ITTO20100237A1/it
Priority to EP11721645.7A priority patent/EP2552485B1/en
Priority to EA201290955A priority patent/EA029198B1/ru
Priority to PCT/IB2011/051284 priority patent/WO2011117848A1/en
Priority to SI201131130A priority patent/SI2552485T1/sl
Priority to CN201180015849.0A priority patent/CN102958539B/zh
Priority to HRP20170490TT priority patent/HRP20170490T1/hr
Priority to US13/637,030 priority patent/US20130022608A1/en
Publication of ITTO20100237A1 publication Critical patent/ITTO20100237A1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • C07K16/108Orthomyxoviridae (F), e.g. influenza virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
IT000237A 2010-03-26 2010-03-26 Immunoglobuline intere della classe delle igg per l'uso come medicamento antinfluenzale ITTO20100237A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT000237A ITTO20100237A1 (it) 2010-03-26 2010-03-26 Immunoglobuline intere della classe delle igg per l'uso come medicamento antinfluenzale
EP11721645.7A EP2552485B1 (en) 2010-03-26 2011-03-25 Full-length immunoglobulins of the igg isotype capable of recognizing a heterosubtype neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
EA201290955A EA029198B1 (ru) 2010-03-26 2011-03-25 Полноразмерные иммуноглобулины изотипа igg, способные к распознаванию нейтрализующего эпитопа в области стебля гемагглютинина различных подтипов и их использование в качестве лекарственного средства против гриппа
PCT/IB2011/051284 WO2011117848A1 (en) 2010-03-26 2011-03-25 Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
SI201131130A SI2552485T1 (sl) 2010-03-26 2011-03-25 Imunoglobulini polne dolžine igg izotipa, sposobni prepoznave heteropodtipskega nevtralizacijskega epitopa na hemagglutininskem izvornem področju in njih uporaba kot zdravilo proti gripi
CN201180015849.0A CN102958539B (zh) 2010-03-26 2011-03-25 能够识别血凝素干区上的杂亚型中和表位的IgG同种型全长免疫球蛋白和其作为抗-流感药物的应用
HRP20170490TT HRP20170490T1 (hr) 2010-03-26 2011-03-25 Imunoglobulini pune dužine igg izotipa sposobni za prepoznavanje heterosubtipnog epitopa neutralizacije na području stabljike hemaglutinina i njihova uporaba kao lijek protiv gripe
US13/637,030 US20130022608A1 (en) 2010-03-26 2011-03-25 FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000237A ITTO20100237A1 (it) 2010-03-26 2010-03-26 Immunoglobuline intere della classe delle igg per l'uso come medicamento antinfluenzale

Publications (1)

Publication Number Publication Date
ITTO20100237A1 true ITTO20100237A1 (it) 2011-09-27

Family

ID=42938492

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000237A ITTO20100237A1 (it) 2010-03-26 2010-03-26 Immunoglobuline intere della classe delle igg per l'uso come medicamento antinfluenzale

Country Status (1)

Country Link
IT (1) ITTO20100237A1 (it)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009115972A1 (en) * 2008-03-17 2009-09-24 Pomona Biotechnologies Llc Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009115972A1 (en) * 2008-03-17 2009-09-24 Pomona Biotechnologies Llc Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes

Similar Documents

Publication Publication Date Title
EP2768531A4 (en) MEGLUMIN-STABILIZED ETANERCEPT FORMULATIONS
IL238784A0 (en) Conjugates for treating diseases caused by psma expressing cells
EP2935321A4 (en) CHIMERIC ANTIGEN RECEPTORS
DK3195880T3 (da) Højkoncentrerede anti-sclerostin-antistofformuleringer
EP2704573A4 (en) AMINOMETHYL biaryl BENZOTRIAZOL DERIVATIVES
EP2866833A4 (en) CRYSTALLINE ANTIBODIES AGAINST HUMAN IL-23
IL227990B (en) Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione for preparation of medicaments for treatment of immune-related and inflammatory diseases
EP2802850A4 (en) ANASTIGMATIC IMAGING PECTOGRAPH
DK3091029T3 (da) Anti-IL13-antistofformuleringer
EP2895500A4 (en) ANTIKÖRPEREVOLUTIONSIMMUNOGENE
CO6801637A2 (es) Formulaciones de anticuerpos
EP2918242A4 (en) MOUTH CLEANING DEVICE
SI3513806T1 (sl) Sestava imunogena
SMT201500057B (it) Uso della biotina per il trattamento della sclerosi multipla
IT1402018B1 (it) Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
FR2962650B1 (fr) Composition d'immunoglobulines humaines concentrees
BR112012031861A2 (pt) uso de 5a-androstano (alquil)-3b, 5, 6b-triol
EP2721029A4 (en) Imidazopyridine-2-ON DERIVATIVES
DK3498313T3 (da) Rørformede proteser
FR2961107B1 (fr) Composition d'immunoglobulines humaines stabilisee
IL240114A0 (en) B cell lineage based immunogen design with humanized animals
EP2924048A4 (en) RTRAIL MUTANT AND MONOMETHYL AURISTATIN E-CONJUGATE THEREOF
EP2917174A4 (en) PREPARATION OF INTERMEDIATE PRODUCTS OF X-RAY CONTAINERS
HRP20181799T1 (hr) Optimizirana farmaceutska formula, namijenjena liječenju upalnih promjena jednjaka
BR112014021240A2 (pt) uso de igg policlonal